Status:
COMPLETED
Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis
Lead Sponsor:
Hamad Medical Corporation
Conditions:
Gastroenteritis
Eligibility:
All Genders
1-14 years
Phase:
PHASE4
Brief Summary
Is intravenous metoclopramid as effective as intravenous ondansetron in the treatment of persistent vomiting in patients with acute gastroenteritis.
Detailed Description
In this study, we will compare the efficacy of a single intravenous dose of ondansetron versus intravenous metoclopramide in the treatment of persistent vomiting in simple gastroenteritis in a larger ...
Eligibility Criteria
Inclusion
- All acute gastroenteritis patient between 1-14 years presenting to PEC Al Saad with diarrhea, persistent vomiting , fail oral rehydration and admitted to the observation unit for intravenous hydration will be eligible for the study.
Exclusion
- Previous abdominal surgery
- Suspicion of surgical abdominal
- Bile stained vomitus
- History of hepatic and renal illnesses
- In-born error of metabolism
- Children with shock or impending shock
- Sever dehydration.
- Previous hypersensitivity or abnormal reaction to metoclopramide or ondansetron
- Antiemetic treatment within 48 hours prior to presentation.
- Seizure disorder
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT01165866
Start Date
June 1 2008
End Date
December 1 2008
Last Update
October 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Emergency Centre, Al-Saad
Doha, Qatar